Survival analysis of non-small cell lung cancer using TKI treatment-- A multi-center retrospective s

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:acb13202
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: To assess differences in overall survival among patients with NSCLC using TKIs in first or second line treatment and different TKIs.Method: Collecting patients data in CRF and use SPSS software for statistical analysis.
其他文献
  Objective: Patients (pts) with right middle lobe non-small cell lung cancer (NSCLC) were not well studied.This study analyzed the prognostic factors in rese
会议
  Background: Concurrent chemoradiation therapy or induction chemotherapy plus surgery were considered as standard treatment to non-small-cell lung cancer (NS
会议
  Objective: Lung cancer is the leading cause of cancer-related deaths worldwide with 85% of non-small cell lung cancer (NSCLC) and squamous cell carcinomas (
会议
  Objective: Proteinkinase CK2 (also known ascasein kinase) is a highlyconserved seine/threonine protein kinase, which is ubiquitously expressed inmammalian c
会议
  Objective: To investigate the efficacy and safety of the treatment of nitroglycerin combined with docetaxel/carboplatin chemotherapy for the elderly patient
会议
  Objective: Several phase Ⅲ studies demonstrated that, compared with traditional chemotherapy, epidermal growth factor receptor-tyrosine kinase inhibitors (
会议
  目的:脑膜癌病临床表现多种多样,缺乏特异性,因此极易漏诊、误诊。现通过收集我院脑膜癌病患者的临床资料,总结临床特征,旨在提高临床医师对本病的认识。方法:通过回顾性分析20
  目的:探讨动态监测131I治疗前刺激性甲状腺球蛋白(preablative stimulated thyroglobulin,ps-Tg)变化在伴有远处转移的分化型甲状腺癌(differentiated thyroid cancer,DTC
  Objective: Patients (pts) with SCLC respond to initial platinum (PLT) based chemotherapy (CT), but rapidly progress.Combined blockade of programmed death-1
会议
  目的:淋巴结转移是甲状腺乳头状癌(Papillary Thyroid Carcinoma,PTC)治疗决策中的关键性因素。本研究的目的是寻找包括年龄在内的甲状腺微小乳头状癌(Papillary Thyroid